Kernal Biologics

Developer of mRNA therapeutics for immuno-oncology using deep learning technology

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups18 employees language kernalbio.com

Registered entities

Social engagement

Social engagement: 4.9K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

22 investors on record; lead investors include Hummingbird Ventures.

Investor typeCountShare
Venture capital1777%
Private equity15%
Accelerator & incubator15%
Other / undisclosed314%

Recent activity

30 Apr 2026
Event
ASGCT 2026
7 Oct 2025
Milestone
regulatory
3 Oct 2025
Partnership
Lilly Gateway Labs
Coming soon